May 13, 2013 by Max MacalusoWhat Does This Failure Mean for Eli Lilly Investors?Eli Lilly announced that it will stop developing cancer drug candidate enzastaurin. What does this mean for its business?
May 12, 2013 by Max Macaluso4 Technologies That Can Help Track Weight LossApps and devices that help patients being treated for obesity track their progress.
May 10, 2013 by Max Macaluso and Dave WilliamsonThis Week in Health CareFor the week ended May 10, 2013.
May 9, 2013 by Max MacalusoWhy NPS Pharmaceuticals Is Up After EarningsOrphan drugmaker NPS Pharmaceuticals reveals the progress of its Gattex launch.
May 8, 2013 by Max Macaluso3 Key Takeaways From Keryx's Earnings ReportWhat should investors focus on after this biotech's Q1 report?
May 7, 2013 by Max MacalusoIs Orexigen Therapeutics Burning Too Much Cash?What is this biotech's burn rate?
May 7, 2013 by Max Macaluso and Dave WilliamsonThis Week in Health CareFor the week ended May 3, 2013.
May 2, 2013 by Max MacalusoHot Off the Press: Arena Pharmaceuticals’ First Quarter ResultsInitial takeaways from Arena's Q1 report.
Apr 26, 2013 by Max MacalusoIs a Pharmaceutical Company the Same as a Biotech?Have they become the same, or do they have different approaches to drug discovery?
Apr 26, 2013 by Max MacalusoTeva's 3 Biggest ChallengesTeva is one of the largest pharmaceutical companies in the world, but what roadblocks lie ahead?
Apr 25, 2013 by Max Macaluso1 Simple Way to Be a Better InvestorTrying to weight the pros and cons of a potential investment? SWOT away your worries and try this approach.
Apr 24, 2013 by Max Macaluso2 Upcoming Catalysts for AmarinTwo important events that Amarin investors need to watch.
Apr 22, 2013 by Max MacalusoWhy This Obesity Drugmaker's Prescription Data Tells Only Half the StoryVivus released prescription data for its obesity drug Qsymia last week, but its earnings report is more important.
Apr 22, 2013 by Max Macaluso and Dave WilliamsonThis Week in Health CareThe Motley Fool's weekly health care show.
Apr 18, 2013 by Max MacalusoObesity and Weight Management: How Much Weight Loss is Actually Necessary?Obesity is a serious disease, but 5%-10% of weight loss may be enough to make a dramatic impact on a patient's health.
Apr 18, 2013 by Max Macaluso and Dave Williamson2 Things Regeneron Investors Need to WatchWhich issues should Regeneron investors focus on today?
Apr 17, 2013 by Max MacalusoHow Allergy Season Taught Me an Important Investing LessonA look at how big pharma brands and markets its products.
Apr 14, 2013 by Max Macaluso and Dave WilliamsonThis Week in Health CareThe Motley Fool's weekly health-care show.
Apr 11, 2013 by Max Macaluso and Sharon YepWant to Retire Soon? Don't Invest in This Industry!There are many different strategies investors can use to protect their wealth as they near retirement --- but investing in this industry is a risk that may not be worth taking.
Apr 10, 2013 by Max MacalusoThe Hidden Industry That's Saving Your LifeMedical-waste disposal companies are the unsung heroes of the health-care industry, and this company is one of the dominant players.
